- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $13.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.86M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $86.99M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $80.68M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $43.21M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $41.83M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $48.38M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $47.2M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $24.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $15.74M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $148.5M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $141.22M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 23.16M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.07M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $5.94M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$971K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$854K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $18.18M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $21.31M |